Bhavin Shah, MD
Surgical Oncology · Joliet, ILNPI 1306078910
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Medtronic at 57.3% of the total. Reporting peaked in 2022 at $1,339 and has fallen 85.0% since, to $201 in 2025. That places this record below the midpoint for surgical oncology clinicians in IL, where the typical reported total is $2,301.
Across 45 payments — averaging $51.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Johnson & Johnson$301
- Braintree Laboratories, Inc.$113
- Integra Lifesciences Corporation$103
- AbbVie$102
- Merck$83
- plus $281 from 9 others
What the payments were for
- Consulting fees$1,01544%
- Food & beverage$1,28656%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 7 | $1,318 |
| Johnson & Johnson(2 entities) | 6 | $301 |
| Braintree Laboratories, Inc. | 7 | $113 |
| Integra Lifesciences Corporation | 3 | $103 |
| AbbVie | 6 | $102 |
| Merck | 5 | $83 |
| Organogenesis Inc. | 2 | $49 |
| Biosense Webster, Inc. | 1 | $46 |
| Aroa Biosurgery Incorporated | 2 | $38 |
| Coopersurgical, Inc. | 1 | $35 |
| Kerecis Limited | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Smith+Nephew | 1 | $23 |
| Angiodynamics, Inc. | 1 | $20 |
| Acera Surgical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LigaSure$210
How this compares
$2,301 in reported general payments places this provider in the 50th percentile of 55 surgical oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 22 | $1,425 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $127 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Joliet
- Fadi DahdalehChicago$198K
- Claudius ConradUrbana$174K
- Nora HansenChicago$41K
- Jeffrey WayneChicago$38K
- David BentremChicago$34K
- Mecker MollerChicago$25K
- Akhil ChawlaWarrenville$17K
- Shishir MaithelChicago$16K
- Ashley HardyWarrenville$16K
- Aslam EjazChicago$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.